|
 |
|
|
|
 |
|
|
 |
|
 |
|
|
Four research entities join their efforts to reach high level biomedical research
|
|
|
|
| |
 |
| |
| |
|
|
 |
Institut d'Investigacions
Biomèdiques August
Pi i Sunyer (IDIBAPS), founded in 1993, is
a research centre formed by the Generalitat
de Catalunya's Ministry
of Universities, Research and the Information
Society (DURSI), the University
of Barcelona's Faculty
of Medicine, the Hospital
Clínic of Barcelona and the Institut d'Investigacions
Biomèdiques de Barcelona of the Council
for Scientific Research
(IIBB-CSIC).
+
Information
Furthermore, with a spirit
of collaboration, IDIBAPS is immersed in projects
like Barcelona
Biomedical Alliance (BBA) and the Catalan
Association of Research Institutions (Associació
Catalana d'Entitats de Recerca). These enterprises,
supported by DURSI
and the Science
and Technology Ministry of Spain will turn
Catalunya and Barcelona into an important international
pole of biomedicine. On the other hand, IDIBAPS
is highly involved in the development of the national
network of cooperative research financed by
the Health Ministry. Their researchers participate
in a total of 37 networks of groups and centres,
and they coordinate five of them.
|
 |
| |
|
|
|
|
|
| |
 |
|
|
|
 |
| |
Translational research to minimise
the barriers between the laboratory
and the physician's surgery
|
|
| |
|
|
 |
|
| |
 |
|
| |
|
A shared space in downtown Barcelona makes easier the cooperation between Institutions forming IDIBAPS
|
|
|
|
 |
|
|
| |
 |
|
| |
 |
| |
| |
|
|
 |
- Management infrastructure
The
administrative infrastructure that supports
the research work of the IDIBAPS, capable
of managing and generating resources as well
as employing technical personnel, is the responsability
of the Fundació Clínic per a
la Recerca Biomèdica. IDIBAPS is jointly
financed by the European
Union through the European
Regional Development Fund (ERDF).
IDIBAPS' governing organ is the Board of Governors.
The director of IDIBAPS is Dr. Joan Rodés,
the director of research at the Hospital
Clínic de Barcelona.
- Research staff
The
scientists at IDIBAPS come from the various
research centres that make it up: the Faculty
of Medicine of the University of Barcelona,
the Hospital Clínic of Barcelona, the Institut
d'Investigacions Biomèdiques de Barcelona-CSIC,
and the personnel contracted by the Fundació
Clínic. The current number of researchers
attached to IDIBAPS is around 300. Furthermore,
there is a large team of graduates of differing
levels and scholars dedicated to research
tasks that support the research lines carried
out by IDIBAPS scientists. The work of some
investigators is financed by programmes of
the Fondo
de Investigación Sanitaria, the Institució
Catalana de Recerca i Estudis Avançats (ICREA)
and the Ramón
y Cajal.
- Board of Governors
of IDIBAPS
President
Mr. Ramon Moreno i Amich
(Research Manager of the Generalitat de Catalunya)
Vice-president
Dr. Emili Gelpí i Monteys
(Manager of Institut d’Investigacions
Biomèdiques de Barcelona)
Members
Prof. Teresa Estrach Panella
(Dean of the Faculty of Medicine, Universitat
de Barcelona)
Dr. Juan Rodés i Teixidor
(Scientific director of IDIBAPS and General
Manager of Hospital Clínic de Barcelona)
Dr. Lluís Calvo i Calvo
(CSIC Coordinator in Catalonia)
Marta Aymerich
(Manager of the Agència d’Avaluació
i Tecnologia Mèdica)
Dr. Ramón Gomis Barberà
(Research Manager of IDIBAPS)
Carme Muñoz
(Vice-Chancellor of Scientific Science Policy
in Universitat de Barcelona)
Dr. Josep Maria Piqué Badia
(Medical Manager of Hospital Clínic
de Barcelona)
Joan Bigorra
(Fundació Clínic per a la Recerca
Biomèdica Director)
Secretary
Mr. Emili Bargalló
(Manager of IDIBAPS and Fundació Clínic
for Medical Research)
|
 |
| |
|
|
|
|
| |
- Scientific Council of
IDIBAPS
Jesús Ávila (Centre
of Molecular Biology Severo Ochoa, Madrid)
José A. Berciano (Neurology Service, Hospital
Universitario Marqués de Valdecilla, Santander)
Lisardo Bosca (Biochemistry Institute,
Universidad Complutense, Madrid)
Jesús Florez (Department of Physiology and
Pharmacology, Faculty of Medicine, Universidad de
Cantabria, Santander)
Valentí Fuster (Cardiovascular Institute, Mount
Sinai Hospital, Nova York)
Roberto Gallego (Neurosciences Institute, Universidad
Miguel Hernández, Alicante)
Francisco Javier García-Sancho (Biology and
Molecular Genetics Institute, Faculty of Medicine,
Valladolid)
Roberto Groszmann (Hepatic Hemodynamic Lab.
Yale University Sch. Med, West Haven)
José López Barneo (Department of Medical Physiology
and Biophysics, Faculty of Medicine, Sevilla)
Carlos López Otín (Department of Biochemistry
and Molecular Biology, Universidad de Oviedo)
Joan Massagué (Memorial Sloan Kettering Cancer
Center, Nova York)
José M. Mato (Laboratory of Biochemistry and
Molecular Biology, Universidad de Navarra, Pamplona)
Federico Mayor (Molecular Biology
Centre, Severo Ochoa, Madrid)
Ginés Morata (Molecular Biology Centre, Severo
Ochoa, Madrid)
Daniel Navajas (Unit of Biophysics and Bioengineering,
Universitat de Barcelona)
Pere Pascual (Department of Structure and Constituents
of Matter, Faculty of Physics, Universitat de Barcelona)
Miguel A. del Pozo (Cell Signalling
by Integrins Laboratory, Centro Nacional de Investigaciones
Cardiovasculares (CNIC))
Ciril Rozman (Haematology Service,
Hospital Clínic de Barcelona, Universitat de
Barcelona)
Margarita Salas (Molecular Biology Centre,
Severo Ochoa, Madrid)
Jesus San Miguel (Haematology Service,
Hospital Clínico de Salamanca)
Francisco Sánchez-Madrid (Immunology
Service, Hospital de la Princesa, Madrid)
Eugenio Santos (Cancer Research Centre,
Salamanca)
|
| |
|
 |
|
 |
|
| |
|
|
| |
|
| |
|
The promotion of the shared use of the scientific and technical services is a strategic option open to other public or private institutions
|
|
|
 |
|
| |
 |
|
|
 |
| |
 |
| |
 |
In any scientific project, it is essential to demonstrate that the research staff has the scientific and intellectual capacity to carry out the proposed objectives. Today, the simplest and most reliable way to demonstrate this capacity is through the analysis of scientific production based on the publications and on the journals where original articles have been published. The impact factor of these journals is a useful measure to estimate the scientific quality of the researchers in a particular institution.
The
scientific production of the investigators who
are part of DIBAPS is very high. In the last five
years, they have published 2,256 original articles.
The actual impact factor of each article is 6*.
The global impact factor for the journals where
the above-mentioned articles have appeared is
8,875.839 points. Of these publications, 63% are
in the first quartile of each specialisation,
which means it one of the most out-standing journals.
The annual median is 450 articles, with an average
impact factor of 3,934 points.
Official statistics of the European Union show that the CSIC and the Universidad de Barcelona are the two most productive scientific institutions in Spain. According to the first bibliometric map on biomedicine in Spain (2002; J. Camí, Mapa
de la producción científica española en biomedicina
y ciencias de la salud), the Hospital Clínic de Barcelona heads the list of hospital centres with the greatest scientific production in Spain, with more than 2,900 publications between 1994 and 2000. The Clínic is among the ten hospitals of the EU in terms of the greatest scientific production. The collaboration among IDIBAPS' three scientific institutions, together with the institutional support of the
Ministry of Universities, Research and Information Society de la Generalitat
de Catalunya, guarantees sufficient critical mass to support and to increase the positive results of its research projects.
* Calculated by dividing the total number of citations by the total number of published articles. |
 |
| |
|
|
|
|
 |
| |
|
| |
A sufficient critical mass of researchers to continue leading scientific production in Spain
|
|
|
|
 |
|
 |
 |
|
The aim of our institution it is to look for a balanced between public and private funding
|
|
|
| |
 |
| |
| |
|
|
 |
All
of this IDIBAPS scientific production has been
carried out by its own researchers. But, without
a doubt, it would have been impossible without
the financial support given to the institution
by official agencies such as: Fondo
Europeo de Desarrollo Regional (Unión Europea),
Fondo de Investigación Sanitaria (Ministerio
de Sanidad y Consumo), Centro
de Investigación Científica y Tecnológica,
Comissió Interdepartamental de Recerca i Innovació
Tecnològica (Generalitat
de Catalunya), Agencia
Española de Cooperación Internacional
y National
Institutes of Health from United States. The
global public funds received from agencies during
the 1997-2001 period raises to 32.460.000 euros.
During the same period, the economic resources
from private sector have raised to 25.728.000
euros.
The
amounts for the year 2003 contributed by each
institution forming IDIBAPS are: University of
Barcelona, 3,621,223 euros; Institut d'investigacions
Biomèdiques de Barcelona of CSIC, 2,987,551€;
Hospital Clínic of Barcelona, 17,910,876€;
Fundació Clínic, 1,800,000 euros;
Generalitat of Catalonia through DURSI, 1,800,000;
and from the projects awarded to researchers,
4,308,757 €. A total of 49,066,677€.
This is a clear demonstration of the fact that
the institutions which form part of IDIBAPS and
the researchers have complete confidence in IDIBAPS's
scientific project.
|
 |
 |
|
|
| |
Open a graphic about IDIBAPS last years public and private funding |
|
|
|
| |
 |
|
|
| |
 |
|
 |
|
| |
|
|
|
|
 |
|
| |
|
|
|